Back to search

Article

Pharmacogenetic Role of the Synaptosomal-Associated Protein 25 Gene in Clinical Response to Methylphenidate Among Turkish Pediatric ADHD Cohort

2026-05-25

Abstract excerpt

<title>Abstract</title> <p> Background Methylphenidate (MPH) is a first-line treatment for attention-deficit/hyperactivity disorder (ADHD). MPH blocks dopamine and norepinephrine transporters, increasing synaptic catecholamine levels. Neurotransmitter release depends on presynaptic vesicle docking and fusion mediated by Synaptosomal-Associated Protein, 25 kDa (SNAP-25), a Target Soluble NSF Attachment Protein R...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e3c4cf3-09cc-59b0-880f-9eaf948be64c
DOI
10.21203/rs.3.rs-9641413/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacogenetic Role of the Synaptosomal-Associated Protein 25 Gene in Clinical Response to Methylphenidate Among Turkish Pediatric ADHD CohortDOI 10.21203/rs.3.rs-9641413/v1
Select a neighboring publication to make it the new centre.